Based on the well-documented interplay between pH and immune response6–9, and the absence of an antitumor effect of Slc4a4 inhibition in immunodeficient mice, we studied the immune landscape after SLC4A4 depletion in cancer cells. The gene discussed is SLC4A4; the disease is cancer.